Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2016

Feb 3, 2016

30150_dirs_2016-02-03_9f1fd055-d560-4988-b780-2846899b3063.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2016-02-01

Reporting Person: Lewis William (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-01 Common Stock P 50000 $13.34 Acquired 96972 Direct

Footnotes

F1: Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 17, 2015.

F2: The price in column 4 is a weighted average price. The prices actually paid by the Reporting Person in these transactions range from $12.97 to $13.63.

F3: The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range reported.